| Oral presentation schedule for October 24 (Fri), Day 2 |
| |
|
Kobe International Exhibition Hall No.2 Building |
Portopia Hotel |
Kobe International Conference Center |
Kobe International Exhibition Hall No.1 Building |
Kobe International Exhibition Hall No.3 Building |
Portopia Hotel |
|
| |
|
Hall (North) |
Hall (South) |
Conference Room 3A |
Portopia Hall |
Ohwada A |
Ohwada B |
Ohwada C |
Kairaku 1+2 |
Kairaku 3 |
Waraku |
Topaz |
Main Hall |
International Conference Room |
Digital Poster Session & Commercial Exhibition |
Digital Poster Session & Commercial Exhibition |
Emerald |
|
| |
|
Room 1 |
Room 2 |
Room 3 |
Room 4 |
Room 5 |
Room 6 |
Room 7 |
Room 8 |
Room 9 |
Room 10 |
Room 11 |
Room 12 |
Room 13 |
Room 14 |
Room 15 |
Room 16 |
|
| 8:00 |
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00 |
| 45 |
|
No planned seminars |
No planned seminars |
No planned seminars |
No planned seminars |
Breakfast
Seminar5 Century Medical Inc.
Impressive Case –The reason to be a Hepato-Biliary-Pancreas endoscopic surgeon– |
Breakfast
Seminar6 Otsuka Pharmaceutical Co., Ltd.
New strategies for NSAIDs-induced gastrointestinal damage |
Breakfast
Seminar7 ABBOTT JAPAN Co., LTD.
The utility of serum pepsinogen levels for the diagnosis of Helicobacter pylori associated gastritis |
Breakfast
Seminar8 ASKA Pharmaceutical Co., Ltd./ NIHON PHARMACEUTICAL CO., LTD
Key points and techniques for comfortable endoscopy |
Breakfast
Seminar9 DAIICHI SANKYO CO., LTD./ AstraZeneka K.K.
A correct comprehension of Gastric cancer risk classification (ABC classification) –To prevent from overlooking high risk group A– |
Breakfast
Seminar10 Takeda Pharmaceutical Company Limited
The Essence of Endoscopic Diagnosis Not to Overlook Infectious Gastritis of Helicobacter pylori |
Breakfast
Seminar11 Eisai Co., Ltd.
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma in Japan |
Breakfast
Seminar12 Takeda Pharmaceutical Company Limited
Possible interaction between life style-related diseases and gastrointestinal-liver diseases: especially focused on NASH |
Breakfast
Seminar13 MIYARISAN PHARMACEUTICAL CO., LTD.
The New Era of Probiotics Research in ｔhe Field of Inflammatory Bowel Disease |
|
|
|
45 |
| 9:00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
9:00 |
| 30 |
|
S8 (JSGE/JGES)
A new era of H. pylori research - From pathophysiology to eradication - Chair: T. Sugiyama
K. Murakami |
S9 (JGES)
Up-to-date evidence in image enhance endoscopy and microscopic
endoscopy for the upper GI tract Chair: M. Kaise
H. Inoue |
S11 (JGES/JSGE/
JSH/JSGS)
Update on treatment of gastric varices and problems to be solved. Chair: K. Obara
S. Kokubu |
PD8 (JSH/JSGE)
The cutting edge of therapeutic strategies for liver diseases based on imaging modalities Chair: F. Moriyasu
Y. Imai |
IS-S4 (JSGE)
Therapeutic strategy of IBS based on pathophysiology Chair: Y. Fujiyama
S. Fukudo |
W5 (JGES)
ESD update-Innovation in techniques and devices-Lower GI Chair: H. Yamamoto
T. Toyonaga |
PD10 (JSGCS/
JGES)
Status quo and problems of organized screening by endoscopy Chair: M. Kobayashi
M. Yasuda |
PD11 (JSH/JSGE/
JGES/JSGS)
New therapeutic strategies for complications in patients with liver cirrhosis Chair: Y. Murawaki
H. Moriwaki |
Live broadcast Room 1 |
Live broadcast Room 2 |
Live broadcast Room 3 |
W8 (JSH/JSGE)
Future perspective of hepatology in terms of transition of life style and liver pathogenesis Chair: E. Hashimoto
Y. Takei |
W9 (JSGE/JGES)
Intractable and rare disorders of the gastrointestinal tract Chair: T. Matsumoto
T. Kanai |
| Commercial Exhibition |
|
Commercial Exhibition |
Gastrointestinal and Pancreaticobiliary Endoscopy Live Seminar (JGES) |
30 |
| 10:00 |
Digital Poster Session
(JSGE)
9:30-11:30 |
|
|
Digital Poster Session
(JSGCS)
9:30-11:30 |
|
|
10:00 |
| 11:00 |
|
|
|
11:00 |
| 10 |
|
Invited Lecture (Keynote Lecture) (JSGE)
Therapeutic strategy for IBS and FD based on pathophysiology N. Talley
Chair: S. Fukudo |
|
|
10 |
| 20 |
Special Lecture (JSGCS)
Gastrointestinal cancer screening - Trends in the world and a prospect in Japan H. Saito
Chair: K. Inoue |
20 |
| 30 |
Invited Lecture (JGES)
GI endoscopy abroad: Experience from a 45 year career in the USA C. Sugawa
Chair: R. Fujita |
30 |
| 12:00 |
|
|
12:00 |
| 30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
| 13:00 |
Luncheon
Seminar39 DAIICHI SANKYO CO., LTD./ AstraZeneka K.K.
Re-evaluation of the management of drug-induced GI injury |
Luncheon
Seminar40 Nippon Kayaku Co., Ltd.
New Strategy in Transcatheter Arterial Chemoembolization |
Luncheon
Seminar41 Abbott Japan Co., Ltd.
Japanese Chronic Constipation Treatment’s “Galapagos Syndrome” |
No planned seminars |
Luncheon
Seminar42 AbbVie G.K./ Eisai Co., Ltd.
New treatment strategies in Ulcerative Colitis |
Luncheon
Seminar43 Olympus Medical Systems Corp.
New trend of ESD –Pursue the safer and more reliable treatment– |
Luncheon
Seminar44 Meiji Co., Ltd.
Management of Helicobacter pylori infection in Japan |
Luncheon
Seminar45 CHUGAI PHARMACEUTICAL CO., LTD.
The 7th CHUGAI Award Ceremony
Antiviral treatment for chronic hepatitis C –Current status and future perspective– |
Luncheon
Seminar46 AJINOMOTO PHARMA CEUTICALS CO., LTD.
What is the best treatment strategy for Crohn’s disease in Europe and Japan? |
Luncheon
Seminar47 Otsuka Pharmaceutical Co., Ltd.
Ceremony & Luncheon Seminar
Significance and Importance of then Nutrition Treatment in Liver Cirrhosis |
Luncheon
Seminar48 Nippon Boehringer Ingelheim Co., Ltd / Eli Lilly Japan K.K.
How should we treat hyperglycemia to reduce the risk of diabetic complications |
Luncheon
Seminar49 Takeda Pharmaceutical Company Limited
GERD and obesity |
Representative Conference (Japanese Society of Gastrointestinal Cancer Screening)
12:30-13:30 |
13:00 |
| 30 |
|
|
|
|
30 |
| 40 |
|
40 |
| 14:00 |
|
|
|
|
|
|
|
|
|
|
|
|
14:00 |
| 30 |
|
PD7 (JSH/JSGE/
JSGS)
Multidisciplinary therapy of advanced heatocellular carcinoma from the viewpoint of prognosis and QOL Chair: Y. Ku
M. Kudo |
S10 (JGES)
Up-to-date evidence in image enhance endoscopy and microscopic endoscopy for the lower GI tract Chair: H. Ogata
S. Tanaka |
W4 (JSGE/JGES)
Revisited gastro-duodenal defense mechanism Chair: K. Higuchi
Y. Naito |
Special Lecture (JGES)
Surgery or endoscopy? Endoscopic science from a view-point of a surgeon M. Kaminishi
Chair: K. Kumagai |
Invited Lecture (Keynote Lecture) (JSGE)
The microbiota in IBD F. Shanahan
Chair: H. Nakase |
Integrated Program1 (JDDW(JSH)/JSH/JSGS)
Treatment options and their selection for patients with metastatic liver tumor Chair: S. Shiina
H. Baba |
Lecture by Congress President (JSH)
Endotoxin research and hepatology: Evolving science over the past half century H. Fukui
Chair: M. Imawari |
W7 (JSH/JSGE/
JSGS)
Optimization of personalized therapy in elderly patients with liver diseases Chair: Y. Osaki
Y. Asahina |
Women's Committee of Japanese Gastroenterology Study Group (JDDW)
Ladies, be tough and gentle! Chair: K. Hino
F. Kurokawa |
Live broadcast Room 1 |
Live broadcast Room 2 |
S12 (JSGE/JGES/
JSH)
Lipid and bile acids metabolism in lifestyle related diseases Chair: S. Tazuma
Y. Matsuzaki |
Report (JSGCS)
Annual report of gastrointestinal cancer screening in Japan, 2012 S. Kitagawa
Chair: O. Hosokawa |
Digital Poster Session
(JGES)
14:00-16:30 |
|
Digital Poster Session
(JSH)
14:00-16:30 |
|
Digital Poster Session
(JSGCS)
14:00-16:30 |
|
International Poster Session
14:00-16:30 |
|
Gastrointestinal and Pancreaticobiliary Endoscopy Live Seminar (JGES) |
30 |
| 40 |
PD9 (JGES/JSGE/
JSGCS)
H. pylori eradication therapy: The search for strategies to reduce gastric cancer mortality Chair: M. Ichinose
N. Uemura |
W10 (JSGCS/JSGE/
JSH)
Subjects to spread the guideline for abdominal ultrasound mass screening Chair: S. Ikeda
T. Hirai |
40 |
| 15:00 |
IS-W1 (JSGE/
JGES/JSGS)
Host-microbial interaction in IBD Chair: A. Andoh
H. Nakase |
15:00 |
| 16:00 |
|
W6 (JSH/JSGE/
JSGS)
Perspectives of pathogenesis and treatment of liver diseases from the aspects of gut-liver axis Chair: S. Sakisaka
M. Yoneda |
16:00 |
| 30 |
|
30 |
| 17:00 |
|
|
17:00 |
| 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10 |
| 30 |
Japan Gastroenterological Endoscopy Society Awards Ceremony |
30 |
| 18:00 |
Incorporated Association Council and Academic Council (Japan Gastroenterological Endoscopy Society)
17:30-18:45 |
No planned seminars |
Satellite
Symposium81 ASAHI KASEI MEDICAL CO., LTD.
Positioning of LCAP as a therapy of ulcerative colitis: a mechanism-based approach |
No planned seminars |
Satellite
Symposium82 FUJIFILM Medical Co., Ltd.
Future Prospects for BLI (Blue LASER Imaging) Diagnosis
Clinical Usefulness in Upper Gastrointestinal Endoscopy |
Satellite
Symposium83 Janssen Pharmaceutical K.K.
|
Setting up the JDDW Banquet Room |
Satellite
Symposium84 FUJIFILM Medical Co., Ltd.
Astellas Pharma Inc.
Exploration of optimal tacrolimus therapy for refractory ulcerative colitis |
Satellite
Symposium85 Bristol-Myers Squibb
New evolution in Chronic hepatitis B treatment
–Strategy based on NAs and IFN therapy– |
Satellite
Symposium86 TOSHIBA MEDICAL SYSTEMS CORPORATION
|
Satellite
Symposium87 Hospira Japan Co., Ltd./ Maruishi Pharmaceutical Co. Ltd.
A novel drug in the sedation of endoscopic therapy- Precedex |
Satellite
Symposium88 Otsuka Pharmaceutical Co., Ltd.
How to make use of Tolvaptan in hepatic edema? |
Satellite
Symposium89 Mitsubishi Tanabe Pharma Corporation
Therapeutic strategy to Improve refractory HCV Patient |
18:00 |
| 30 |
|
|
|
|
30 |
| 45 |
|
|
|
|
45 |
| 19:00 |
|
19:00 |
| 30 |
|
|
|
|
Social Gathering (after the Satellite Seminar) |
|
|
|
|
|
|
|
|
30 |
| 20:00 |
|
|
|
|
20:00 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
